The effects of fibrin and fibrin-agarose on the extracellular matrix profile of bioengineered oral mucosa

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 1, 2013, Pages 10-19

  Martin, S San ^a,b   Alaminos, M ^c   Zorn, T M T ^d   Sanchez Quevedo M C ^c   Garzon I ^c   Rodriguez, I A ^c,e   Campos, A ^c  

^a UNIVERSIDAD DE VALPARAÍSO   (Chile)

^b Centro Regional de Estudios en Alimentos Saludables Valparaiso   (Chile)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Agarose; Constructs; Extracellular matrix; Fibrin; Oral mucosa; Tissue engineering

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; FIBROBLASTS; GENE EXPRESSION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIGHT TRANSMISSION; SCAFFOLDS (BIOLOGY); TISSUE;

AGAROSE; CONSTRUCT; EXTRACELLULAR MATRICES; FIBRILLOGENESIS; FIBRIN; FIBRIN SCAFFOLD; GENE EXPRESSION PROFILES; ORAL MUCOSA; PROTEIN EXPRESSION PROFILES; TISSUES ENGINEERINGS;

COLLAGEN;

AGAROSE; BIGLYCAN; COLLAGEN FIBRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 6; DECORIN; FIBRIN; LAMININ; LAMININ ALPHA1; LAMININ ALPHA2; LAMININ BETA1; PEROXIDASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ARTICLE; BIOENGINEERING; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 84871948071     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.490     Document Type: Article

References (42)

1. Alaminos M, Sánchez Quevedo MC, Muñoz-Ávila JI, et al. 2006; Construction of a complete rabbit cornea substitute using a fibrin-agarose scaffold. Invest Ophthalmol Vis Sci (IOVS) 47: 3311-3317.
2. Alaminos M, Garzon I, Sanchez-Quevedo MC, et al. 2007; Time-course study of histological and genetics pattern of differentiation in human engineered oral mucosa. J Tissue Eng Regen Med 1: 350-359.
3. Albandar JM. 2005; Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 49: 517-532.
4. Aufderheide AC, Athanasiou KA. 2005; Comparison of scaffolds and culture conditions for tissue engineering of the knee meniscus. Tissue Eng 11: 1095-1104.
5. Birk DE, Zycband EI, Woodruff S, et al. 1997; Collagen fibrillogenesis in situ: fibril segments become long fibrils as the developing tendon matures. Dev Dyn 208: 291-298.
6. Birkedal-Hansen H, Moore WG, Bodden MK, et al. 1993; Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250.
7. Buckley CT, Thorpe SD, O'Brien FJ, et al. 2009; The effect of concentration, thermal history and cell seeding density on the initial mechanical properties of agarose hydrogels. J Mech Behav Biomed Mater 2: 512-521.
8. Colognato H, Yurchenco P. 2000; Form and function: the laminin family of heterotrimers. Dev Dyn 218: 213-234.
9. Corsi A, Xu T, Chen XD, et al. 2002; Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17:1180-1189.
10. Feinberg SE, Aghaloo TL, Cunningham LL Jr. 2005; Role of tissue engineering in oral and maxillofacial reconstruction: findings of the 2005 AAOMS Research Summit. J Oral Maxillofac Surg 63: 1418-1425.
11. Ferdous Z, Lazaro LD, Iozzo RV, et al. 2008; Influence of Cyclic Strain and Decorin Deficiency on 3-D Cellularized Collagen Matrices. Biomaterials 29: 2740-2748.
12. Garzón I, Sánchez-Quevedo MC, Moreu G, et al. 2009a; In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosa. J Periodontal Res 44: 588-597.
13. Garzón I, Serrato D, Roda O, et al. 2009b; In vitro cytokeratin expression profiling of human oral mucosa substitutes developed by tissue engineering. Int J Artif Organs 32: 711-719.
14. González-Andrades M, Garzón I, Gascón MI, et al. 2009; Sequential development of intercellular junctions in bioengineered human corneas. J Tissue Eng Regen Med 3: 442-449.
15. Hernandez R, Rupp S, 2009; Human epithelial model systems for the study of Candida infections in vitro: part II. Histologic methods for studying fungal invasion. Methods Mol Biol 470: 105-123.
16. Ionescu AM, de la Cruz Cardona J, González-Andrades M, et al. 2010; UV Absorbance of a Bioengineered Corneal Stroma Substitute in the 240-400 Range. Cornea 29: 895-898.
17. Izumi K, Takacs G, Terashi H, et al. 1999; Ex vivo development of a composite human oral mucosal equivalent. J Oral Maxillofac Surg 57: 571-577.
18. Johnsen M, Lund L, Romer J, et al. 1998; Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671.
19. Lee SB, Jeon HW, Lee YW, et al. 2003; Bio-artificial skin composed of gelatin and (1-->3), (1->6)-beta-glucan. Biomaterials 24: 2503-2511.
20. Llames SG, Del Rio M, Larcher F, et al. 2004; Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 77: 350-355.
21. Llames S, García E, García V, et al. 2006; Clinical results of an autologous engineered skin. Cell Tissue Bank 7: 47-53.
22. Meana A, Iglesias J, Del Rio M, et al. 1998; Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns 24: 621-630.
23. Mohamed MM, Sloane BF. 2006; Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6: 764-775.
24. Moharamzadeh K, Brook IM, Van Noort R, et al. 2007; Tissue-engineered oral mucosa: a review of the scientific literature. J Dent Res 86: 115-124.
25. Moioli EK, Clark PA, Xin X, et al. 2007; Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev 59: 308-324.
26. Muñoz-Corcuera M, Esparza-Gómez G, González-Moles MA, et al. 2009; Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers. Clin Exp Dermatol 34: 456-461.
27. Nieto-Aguilar R, Serrato D, Garzon I, et al. 2010; Pluripotential Differentiation Capability of Human Adipose-derived Stem Cells in a Novel Fibrin-agarose Scaffold. J Biomater Appl 25(7): 743-768
28. Porter SR, Leao JC. 2005; Review article: oral ulcers and its relevance to systemic disorders. Aliment Pharmacol Ther 21: 295-306.
29. Reichl S, Müller-Goymann CC. 2003; The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride. Int J Pharm 2: 191-201.
30. Sanchez-Quevedo MC, Alaminos M, Capitan LM, et al. 2007; Histological and histochemical evaluation of human oral mucosa constructs developed by tissue engineering. Histol Histopathol 22: 631-640.
31. San Martin S, Zorn TM. 2003; The small proteoglycan biglycan is associated with thick collagen fibrils in the mouse decidua. Cell Mol Biol 49: 673-678.
32. Scheller EL, Krebsbach PH, Kohn DH. 2009; Tissue engineering: state of the art in oral rehabilitation. J Oral Rehabil 36: 368-389.
33. Schonherr E, Witsch-Prehm P, Harrach B, et al. 1995; Interaction of biglycan with type I collagen. J Biol Chem 270: 2776-2783.
34. Serrato D, Nieto-Aguilar R, Garzón I, et al. 2009; Comparison of the effect of cryopreservation protocols on the histology of bioengineered tissues. Histol Histopathol 24: 1531-1540.
35. Sloan P. 1991; Current concepts of the role of fibroblasts and extracellular matrix in wound healing and their relevance to oral implantology. J Dent 19: 107-109.
36. Starborg T, Lu Y, Kadler KE, et al. 2008; Electron microscopy of collagen fibril structurein vitro and in vivo including three-dimensional reconstruction. Methods Cell Biol 88: 319-345.
37. Trelstad RL, Silver FH. 1981; Matrix assembly. In Cell Biology of Extracellular Matrix. D Hay (ed.). Plenum Press: New York; 179-215.
38. Vacanti CA. 2006; The history of tissue engineering. J Cell Mol Med 10: 569-576.
39. Vogel KG, Paulsson M, Heinegard D. 1984; Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223: 587-597.
40. Vogel KG, Trotter JA. 1987; The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen and Related Research 7: 105-114.
41. Werb Z. 1997; ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-442.
42. Zhang G, Chen S, Goldoni S, et al. 2009; Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem. 284: 8888-8897.